VANCOUVER, Wash. and NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback